Expectorant activity via tracheal secretion stimulation

The term "expectorant activity via tracheal secretion stimulation" refers to the therapeutic mechanism by which drugs enhance the output of airway mucus, primarily by stimulating the submucosal glands in the trachea. This stimulation may occur via direct action on glandular muscarinic receptors (e.g., through cholinergic agonists like acetylcholine or carbachol) or through local reflexes mediated by sensory neurons[1][2][3]. Increased secretion aids in the removal of viscous mucus from the airways, improving mucociliary clearance, hydrating the airway surface, and helping to expel pathogens and debris. However, this is not a single molecular entity or receptor, but rather a description of a physiological process relevant in the treatment of respiratory conditions such as chronic bronchitis, asthma, and cystic fibrosis. Drugs such as expectorants (guaifenesin), cholinergic agonists, and VIP analogs may act via this pathway[1][2][3].

Other names

Excretory activity of tracheal glandsMucus secretion stimulationAirway secretion stimulation

Stimulation of submucosal gland secretion via muscarinic (cholinergic) receptors; Direct action on gland cells or via local neural reflexes